Inhibitory effects of Ligusticum chuanxiong on the proliferation of rat hepatic stellate cells

Journal of Gastroenterology and Hepatology (Australia)

Volumn 21, Issue 8, 2006, Pages 1257-1265

  Lin, Yun Lian ^a   Lee, Ting Fang ^a   Huang, Yeh Jeng ^a   Huang, Yi Tsau ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Apoptosis; Caspase 3; Cell cycle protein; Hepatic fibrosis; Ligusticum chuanxiong; smooth muscle actin

Indexed keywords

BROXURIDINE; CYCLIN D1; CYCLIN D2; LIGUSTICUM CHUANXIONG EXTRACT; MITOGEN ACTIVATED PROTEIN KINASE; PLANT EXTRACT; PLATELET DERIVED GROWTH FACTOR; PROTEIN P21; PROTEIN P27; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL CYCLE; CELL PROLIFERATION; CELL STIMULATION; CONTROLLED STUDY; CYTOTOXICITY; DNA SYNTHESIS; DOWN REGULATION; EVALUATION; LIGUSTICUM; LIGUSTICUM CHUANXIONG; LIVER CELL; MEDICINAL PLANT; NONHUMAN; PRIORITY JOURNAL; RAT; STELLATE CELL;

EID: 33745675588     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2006.04326.x     Document Type: Article

References (42)

1. Friedman SL. Liver fibrosis: from bench to bedside. J. Hepatol. 2003; 38: S38-53.
2. Lotersztajn S, Julien B, Teixeira-Clerc F, Grenard P, Mallat A. Hepatic fibrosis: molecular mechanisms and drug targets. Ann. Rev. Pharmacol. Toxicol. 2005; 45: 605-28.
3. Pinzani M, Marra F. Cytokine receptors and signaling in hepatic stellate cells. Semin. Liver Dis. 2001; 21: 397-416.
4. Bataller R, Brenner DA. Liver fibrosis. J. Clin. Invest. 2005; 115: 209-18.
5. Gebhardt R. Oxidative stress, plant-derived antioxidants and liver fibrosis. Planta Med. 2002; 68: 289-96.
6. Schuppan D, Jia JD, Brinkhaus B, Hahn EG. Herbal products for liver diseases: a therapeutic challenge for the new millennium. Hepatology 1999; 30: 1099-104.
7. Shimizu I, Ma Y-R, Mizobuchi Y et al. Effects of Sho-saiko-to, a Japanese herbal medicine, on hepatic fibrosis in rats. Hepatology 1999; 29: 149-60.
8. Boigk G, Stroedter L, Herbst H, Waldschmidt J, Riecken EO, Schuppan D. Silymarin retards collagen accumulation in early and advanced biliary fibrosis secondary to complete bile duct obliteration in rats. Hepatology 1997; 26: 643-9.
9. Hsu Y-T, Lin Y-L, Chiu Y-T, Shiao M-S, Lee C-Y, Huang Y-T. Antifibrotic effects of Salvia miltiorrhiza on dimethylnitrosamine-intoxicated rats. J. Biomed. Sci. 2005; 12: 185-95.
10. Wasser S, Ho JMS, Ang HK, Tan CEL. Salvia miltiorrhiza reduced experimentally induced hepatic fibrosis in rats. J. Hepatol. 1998; 29: 760-71.
11. Sakaida I, Tsuchiya M, Kawaguchi K, Kimura T, Terai S, Okita K. Herbal medicine Inchin-ko-to (TJ-135) prevents liver fibrosis and enzyme-altered lesions in rat liver cirrhosis induced by a choline-deficient 1-amino acid-deficient diet. J. Hepatol. 2003; 38: 762-9.
12. Tang W, Eisenbrand G. Ligusticum chuanxiong Hort. In: Tang W, Eisenbrand G, eds. Chinese Drugs of Plant Origin. Berlin: Springer-Verlag, 1992; 609-12.
13. Chang H-S, But PP-H. Chuanxiong. In: Chang H-S, But PP-H, eds. Pharmacology and Applications of Chinese Materia Medica. Singapore: World Scientific Publishing, 1986; 131-10.
14. Sheu JR, Kan YC, Hung WC, Lin CH, Yen MH. The antiplatelet activity of tetramethylpyrazine is mediated through activation of NO synthase. Life Sci. 2000; 67: 937-47.
15. Pang PK, Shan JJ, Chiu KW. Tetramethylpyrazine, a calcium antagonist. Planta Med. 1996; 62: 431-5.
16. Zhang Z, Wei T, Hou J, Li GYuS, Xin W. Tetramethylpyrazine scavenges superoxide anion and decreases nitric oxide production in human polymorphonuclear leukocytes. Life Sci. 2003; 72: 2465-72.
17. Huang Y-T, Chang F-C, Chen K-J, Hong C-Y. Acute hemodynamic effects of tetramethylpyrazine and tetrandrine on cirrhotic rats. Planta Med. 1999; 65: 130-4.
18. Liu CF, Lin CC, Ng LT, Lin SC. Hepatoprotective and therapeutic effects of tetramethylpyrazine on acute econazole-induced liver injury. Planta Med. 2002; 68: 510-14.
19. Vogel S, Piantedosi R, Frnak J et al. An immortalized rat liver stellate cell (HSC-T6): a new cell model for the study of retinoid metabolism in vitro. J. Lipid Res. 2000; 41: 882-93.
20. Takashima T, Kawada N, Maeda N et al. Pepstatin A attenuates the inhibitory effect of N-acetyl-L-cysteine on proliferation of hepatic myofibroblasts (stellate cells). Eur. J. Pharmacol. 2002; 451: 265-70.
21. Chen A, Zhang L, Xu J, Tang J. The antioxidant (-)-epigallocatechin-3- gallate inhibits activated hepatic stellate cell growth and suppresses acetaldehyde-induced gene expression. Biochem. J. 2002; 368: 695-704.
22. Higuchi H, Grambihler A, Canbay A, Bronk SF, Gregory J, Gores GJ. Bile acids up-regulate death receptor 5/TRAIL-receptor 2 expression via a c-Jun N-terminal kinase-dependent pathway involving Sp1. J. Biol. Chem. 2004; 279: 51-60.
23. Imanishi Y, Maeda N, Otogawa K, Seki S, Matsui H, Kawada N. Herb medicine Inchin-ko-to (TJ-135) regulates PDGF-BB-dependent signaling pathways of hepatic stellate cells in primary culture and attenuates development of liver fibrosis induced by thioacetamide administration in rats. J. Hepatol. 2004; 41: 242-50.
24. Kim K-Y, Rhim TY, Choi I, Soung-Soo Kim S-S. N-Acetylcysteine induces cell cycle arrest in hepatic stellate cells through its reducing activity. J. Biol. Chem. 2001; 276: 40591-8.
25. Wang CN, Chi CW, Lin YL, Chen CF, Shiao YJ. The neuroprotective effects of phytoestrogens on amyloid β protein-induced toxicity are mediated by abrogating the activation of caspase cascade in rat cortical neurons. J. Biol. Chem. 2001; 276: 5287-95.
26. Hansen MB, Nielsen SL, Berg K. Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J. Immunol. Methods 1989; 119: 203-10.
27. Cascales C, Mangiapane LH, Brindley DN. Oleic acid promotes the activation and translocation of phosphatidate phosphydrolase from the cytosol to particulate fractions of isolated rat hepatocytes. Biochem. J. 1984; 219: 911-16.
28. Sakata R, Ueno T, Nakamura T, Sakamoto M, Torimura T, Sata M. Green tea polyphenol epigallocatechin-3-gallate inhibits platelet-derived growth factor-induced proliferation of human hepatic stellate cell line LI90. J. Hepatol. 2004; 40: 52-9.
29. Issa R, Williams L, Trim N et al. Apoptosis of hepatic stellate cells: involvement in resolution of biliary fibrosis and regulation by soluble growth factors. Gut 2001; 48: 548-57.
30. Kweon YO, Paik YH, Schnabl B, Qian T, Lemasters JJ, Brenner DA. Gliotoxin-mediated apoptosis of activated human hepatic stellate cells. J. Hepatol. 2003; 39: 38-46.
31. Wright MC, Issa R, Smart DE et al. Gliotoxin stimulates the apoptosis of human and rat hepatic stellate cells and enhances the resolution of liver fibrosis in rats. Gastroenterology 2001; 121: 685-98.
32. Xu J, Lu Y, Chen A. Activation of peroxisome proliferator-activated receptor-gamma contributes to the inhibitory effects of curcumin on rat hepatic stellate cell growth. Am. J. Physiol. Gastrointest. Liver Physiol. 2003; 285: G20-30.
33. Heldin C-H, Westermark B. Mechanism of action and in vivo role of platelet-derived growth factor. Physiol. Rev. 1999; 79: 1283-316.
34. Kumar S, Boehm J, Lee JC. p38 MAP kinases: key signalling molecules as therapeutic targets for inflammatory diseases. Nat. Rev. Drug Discov. 2003; 2: 717-26.
35. Saklatvala J. The p38 MAP kinase pathway as a therapeutic target in inflammatory disease. Curr. Opin. Pharmacol. 2004; 4: 372-7.
36. Marra L, Arrighi MC, Lazi M et al. Extracellular signal-regulated kinase activation differentially regulates platelet-derived growth factor's actions in hepatic stellate cells, and is induced by in vivo liver injury in the rat. Hepatology 1999; 30: 951-8.
37. Varela-Rey M, Montiel-Duarte C, Oses-Prieto JA et al. p38 MAPK mediates the regulation of alpha 1 (I) procollagen mRNA levels by TNF-alpha and TGF-beta in a cell line of rat hepatic stellate cells. FEBS Lett. 2002; 528: 133-8.
38. Poulos JE, Weber JD, Bellezzo JM et al. Libronectin and cytokines increase JNK, ERK, AP-1 activity, and transin gene expression in rat hepatic stellate cells. Am. J. Physiol. 1997; 273: G804-11.
39. Aroor AR, Shukla SD. MAP kinase signaling in diverse effects of ethanol. Life Sci. 2004; 74: 2339-64.
40. Czaja MJ. The future of GI and liver research: editorial perspectives. III. JNK/AP-1 regulation of hepatocyte death. Am. J. Physiol. Gastrointest. Liver Physiol. 2003; 284: G875-9.
41. Murray AW. Recycling the cell cycle: cyclins revisited. Cell 2004; 116: 221-34.
42. Sherr CJ. The Pezcoller lecture: cancer cell cycles revisited. Cancer Res. 2000; 60: 3689-95.